Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia
Open Access
- 4 February 2019
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 11 (2) , e4004
Abstract
Chronic lymphocytic leukemia (CLL) is one of the most common types of leukemia, and the early diagnosis of patients coincides with their proper treatment and survival. If patients are diagnosed late or proper treatment is not applied, it may lead to harmful results. Several methods could be used for the diagnosis of leukemia; some of these include complete blood count (CBC), immunophenotyping, lymph node biopsy, chest X-ray, computerized tomography (CT) scan, and ultrasound. Most of these methods are time-consuming and an application of more than one method will result as intended. This acknowledgment stresses the necessity of rapid and proper diagnosis for leukemia based on clinical and medical findings, inasmuch as it was decided to apply the artificial neural network (ANN) in order to identify a molecular biomarker for rapid leukemia diagnosis from blood samples and evaluate its potential for the detection of cancer. The independent sample t-test was applied with the Statistical Package for the Social Sciences (SPSS; IBM Corp, Armonk, NY, US) software on the microarray gene expression data of Gene Expression Omnibus (GEO) datasets (GSE22529); 12 genes that had shown the highest differences (among parameters whose p-value was less than 0.01) were selected for further ANN analysis. The selected genes of 53 patients were applied to the training network algorithm, with a learning rate of 0.1. The results showed a high accuracy of the relationship between the output of the trained network and the test data. The area under the receiver operating characteristic (ROC) curve was 0.991, which provides proof of the precision and the relationship with identifying Gelsolin as a potential biomarker for this research. With these results, it was concluded that the training process of the ANN could be applied to rapid CLL diagnosis and finding a potential biomarker. Besides, it is suggested that this method could be performed to diagnose other forms of cancer in order to get a rapid and reliable outcome.Keywords
This publication has 25 references indexed in Scilit:
- Untreated Chronic Lymphocytic Leukemia in Lebanese Patients: An Observational Study Using Standard Karyotyping and FISHInternational Journal of Hematologic Oncology, 2017
- Identification of homogeneously staining regions in leukemia patients2013
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelinesBlood, 2008
- Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2005
- MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemiasProceedings of the National Academy of Sciences, 2004
- Molecular Diagnosis of the Hematologic CancersNew England Journal of Medicine, 2003
- Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemiaProceedings of the National Academy of Sciences, 2002
- Chronic lymphocytic leukemia.1999
- Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.1999
- Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 1995